The benefit reached statistical significance in MVI-positive patients, whereas in MVI-negative patients the differences did not achieve significance but remained directionally consistent, likely reflecting limited sample size and event numbers.
← all excerpts
Preoperative TACE with PD-1 inhibitors and TKIs in beyond "up-to-seven" hepatocellular carcinoma: a propensity score matched analysis.
1
—
—